Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-04-22

FDA Approved: METHYLPHENIDATE HYDROCHLORIDE CD — Supplemental Application (Lannett Company, Inc.)

View source ↗

Summary

FDA approved a supplemental application for methylphenidate hydrochloride CD (Lannett), a generic methylphenidate product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • METHYLPHENIDATE HYDROCHLORIDE CD (METHYLPHENIDATE HYDROCHLORIDE)

Snippet

SUPPL AP for METHYLPHENIDATE HYDROCHLORIDE CD (METHYLPHENIDATE HYDROCHLORIDE)